FDA Gives Emergency Authorization of Hydroxychloroquine Use

The Food And Drug Administration (FDA) issued an emergency authorization Sunday for hydroxychloroquine, a drug already used to treat malaria and other ailments, which has shown anecdotal efficacy against coronavirus.

The use of the drug — often paired with azithromycin — has not yet been proven in clinical trials to be effective against the disease. However, given reported success in a growing number of small, non-randomized studies; as well as testimonials from doctors and patients about the use of the “off-label” drug regimen, doctors are said to be prescribing the treatment to patients who are severely ill. Anecdotally, many doctors are taking it prophylactically.

The Department of Health and Human Services (HHS) issued a statement on Sunday:

The U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) to BARDA to allow hydroxychloroquine sulfate and chloroquine phosphate products donated to the Strategic National Stockpile (SNS) to be distributed and prescribed by doctors to hospitalized teen and adult patients with COVID-19, as appropriate, when a clinical trial is not available or feasible.

House Republicans push Johnson to go to war with Senate over SAVE Act

CNN Blames Trump as Looming Mega Sale Has Staffers ‘Freaking Out’

CNN Announces ‘Special Project’ Against ‘Christian Nationalism’

Trump’s Iran strike rocks Texas Senate race as Dems demand ‘war powers,’ GOP applauds president

Texas bar shooting suspect wore ‘Property of Allah’ clothing with Iranian flag

Three US Service Members Killed, Five Seriously Wounded During Operation Epic Fury Against Iran

Burger King Is Altering Its Flagship Burger for the First Time in Nearly 10 Years

Deadly Austin shooting that killed 3 may be ‘act of terrorism,’ FBI says

9 people injured in mass shooting at Riverfront Live in Cincinnati

Enemy within: Counterterrorism experts fear sleeper cells could be poised inside US

Kamala Harris Intervenes at Last Second in TX Dem Senate Race, Endorses Jasmine Crockett

GOP warns Democrats’ DHS shutdown could jeopardize World Cup security

Nancy Guthrie abduction sparks fears over senior safety in affluent communities: expert

Austin Police Kill Armed Gunman After 3 Die, 14 Wounded Bar Shooting

‘I Love Trump’: Viral Videos Show Iranians Praising Trump, Dancing in the Street Following US Strikes

HHS also noted that it had “accepted 30 million doses of hydroxychloroquine sulfate donated by Sandoz, the Novartis generics and biosimilars division, and one million doses of chloroquine phosphate donated by Bayer Pharmaceuticals, for possible use in treating patients hospitalized with COVID-19 or for use in clinical trials.”

Earlier, the French government had approved similar drugs to treat the virus.

Amid concerns that the sudden interest in hydroxychloroquine could cause shortages, HHS noted: “Use of the donated medications is expected to help ease supply pressures for the drug, and the FDA is also working with manufacturers of chloroquine and hydroxychloroquine to increase production to ensure these drugs also remain available for patients dependent on them for treatment of malaria, lupus and rheumatoid arthritis.”